References

  1. Brown KM, Arthur Jr. Seleniumselenoproteins and human health a review. Public HealthNutr.2001; 4(2B):593-9. PubMed | Google Scholar

  2. Kryukov GV, Castellano S, Novoselov SVet al. Characterization of mammalian selenoproteomes. Science.2003; 300(5624):1439-43. PubMed | Google Scholar

  3. Arthur JR, Beckett GJ. New metabolic roles for selenium.ProcNutrSoc.1994; 53(3):615-24. PubMed | Google Scholar

  4. Hao S, Hu JF, Song S, Huang D, Xu H, Qian G, Huang K. Selenium alleviates Aflatoxin B1-induced Immune toxicity through improving Glutathione Peroxidase 1 and SelenoproteinS Expression in Primary Porcine Splenocytes. J Agric FoodChem.2016;64(6):1385-93. Google Scholar

  5. Yoshida S, Hori E, Ura S, Haratake M, Fuchigami T, Nakayama M. A Comprehensive Analysis of Selenium-Binding Proteins in the Brain Using Its Reactive Metabolite. Chem Pharm Bull (Tokyo). 2016; 64(1):52-8. PubMed | Google Scholar

  6. Naghibi T, Madani S, Mazloomzadeh S, Dobakhti F. Simvastatin's effects on survival and outcome in traumatic brain injury patients: a comparative study. XTurk J Med Sci.2016; 46(1):1-5. Google Scholar

  7. Imam SZ, Newport GD, Islam F, Slikker W, AliSF. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res.1999; 818(2): 575-578. PubMed | Google Scholar

  8. Solovyev ND. Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling. J InorgBiochem.2015; 153:1-12. PubMed | Google Scholar

  9. Meyer CA, Singh R, Jones MT, Yu CG, Power RF, Geddes JW. Dietary Supplementation with Organoselenium Accelerates Recovery of Bladder Expression, but Does Not Improve Locomotor Function, following Spinal Cord Injury. PLoS One. 2016; 11(1):1-12. Google Scholar

  10. Sun RQ, Shi XY, Yang HF, Hao QM, Zhu LC, Liu QL, Niu JJ. An investigation on correlation of severity of brain injury with the expression of activin A and C-reactive protein. Zhonghua Wei Zhong Bing JiJiu Yi Xue. 2013; 25(11):681-5. PubMed | Google Scholar

  11. Su SH, Xu W, Li M, Zhang L, Wu YF, Yu F, Hai J. Elevated C-reactive protein levels maybea predictor of persistent unfavourable symptoms in patients withmild traumatic brain injury: a preliminary study. Brain Behav Immun.2014;38:111-7. PubMed | Google Scholar

  12. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med.1999; 340(6): 448-454. PubMed | Google Scholar

  13. Lee YH, Lee SJ, Lee MK, Lee WY, Yong SJ, Kim SH. Serum selenium levels in patients with respiratory diseases: a prospective observational study. J Thorac Dis.2016; 8(8):2068-78. PubMed | Google Scholar

  14. Maehira F, Luyo GA, Miyagi I, Oshiro M, Yamane N, Kuba M, Nakazato Y. Alterations of serum selenium concentrations in the acute phase of pathological conditions.ClinChimActa. 2002; 316(1-2):137-46. PubMed | Google Scholar

  15. Rayman MP. Dietary selenium: time to act. Br Med J.1997; 314(7078):387-8. PubMed | Google Scholar

  16. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, StotzkyG. Supplementation with selenium and human immune cell functions. Biol Trace Elem Res.1994; 41(1-2):115-27. PubMed | Google Scholar

  17. Baumann H, Gauldie J. The acute phase response. Immunol Today.1994; 15(2):74-80. PubMed | Google Scholar

  18. Chen J, Berry MJ. Selenium and selenoproteins in the brain and brain diseases. J Neurochem.2003; 86(1): 1-12. PubMed | Google Scholar

  19. Vahter M, Lutz E, Lind B, Herin P, Bui T H,Krakau I. Concentrations of copper, zinc and selenium in brain and kidney of second trimester fetus and infants. J Trace Elem Med Biol. 1997; 11 (4): 215-222. Google Scholar

  20. Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. ClinNutr. 2007; 26(1):41-50. PubMed | Google Scholar

  21. Berr C, Nicole A, Godin J, Ceballos-Picot I, Thevenin M, Dartigues JF,Alperovitch A. Selenium and oxygen-metabolizing enzymes in elderly community residents: a pilot epidemiological study. J Am GeriatrSoc. 1993; 41(2):143-148. PubMed | Google Scholar

  22. Angelova EA, Atanassova PA, Chalakova NT, DimitrovBD. Associations between Serum Selenium and Total Plasma Homocysteine during the Acute Phase of Ischaemic Stroke. Eur Neurol.2008; 60(6):298-303. PubMed | Google Scholar

  23. Foaud HM, Labib JR, Metwally HG, El-Twab KM. Plasma D-dimer as a Prognostic Marker in ICU Admitted Egyptian Children with Traumatic Brain Injury. J ClinDiagn Res. 2014;8(9):PC01-6. PubMed | Google Scholar